|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6835 USD | -2.72% |
|
+16.64% | -22.63% |
| 01-29 | Arch Biopartners Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 | CI |
| 01-28 | Arch Biopartners Inc. Auditor Raises 'Going Concern' Doubt | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Development of Innovative Technologies | 3.89M | 965K | 1.98M | 2.12M | 276K | |||||
Total Assets | 2.67M | 622K | 1.17M | 936K | 105K | |||||
Interest Expense | -273K | -309K | -359K | -389K | -258K | |||||
EBT | -1.17M | -1.41M | -3.33M | -3.92M | -1.55M | |||||
Operating Income | -1.16M | -1.39M | -3.36M | -3.95M | -1.5M | |||||
Net Income | -1.17M | -1.41M | -3.33M | -3.92M | -1.55M |
Geographical Revenue Distribution History
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Canada | 3.89M | 965K | 1.98M | 2.12M | 276K |
- Stock Market
- Equities
- ACHFF Stock
- Financials Arch Biopartners Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition